Eli Lilly has announced that it is reducing the list price of its insulin by 70% and capping out-of-pocket costs at $35 a month as part of its Insulin Value Program. Effective immediately, Lilly will ...

Medicare Part D beneficiaries will have a $2,000 cap on out-of-pocket costs for covered drugs beginning in 2025 — but where some people will save, others will inadvertently pay, one author and ...

Pharmaceutical giant Eli Lilly is capping out-of-pocket costs for its insulin at $35 for patients, effective immediately. It's also pledging to cut the price of its most commonly prescribed insulin by ...

I had the beginnings of a post ready after July 1, mostly focused on the fact that the Maple Leafs still had plenty of cap space to do something interesting and that it was worth waiting to fully ...

Despite concerns, legislation to cap out-of-pocket payments for specialty drugs has not been shown to shift costs to health plans, thereby increasing insurance premiums, according to a study published ...